Mutation screening for prenatal and presymptomatic diagnosis: Cystic fibrosis and haemochromatosis

European Journal of Pediatrics, Supplement

Volumn 159, Issue 3, 2000, Pages

  Stuhrmann, M ^a   Graf, N ^a   Dork T ^a   Schmidtke, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cystic fibrosis; Haemochromatosis; Mutation analysis; Screening

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

AUTOSOMAL RECESSIVE DISORDER; CAUCASIAN; CONFERENCE PAPER; CYSTIC FIBROSIS; GENE MUTATION; GENETIC SCREENING; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; ONSET AGE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0034434839     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014400     Document Type: Conference Paper

References (43)

1. Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database
2. Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from North-Eastern Italy: Identification of 90% of the mutations
3. Consensus statement. Hereditary hemochromatosis. Gene discovery and its implications for population-based screening
4. Juvenile and adult hemochromatosis are distinct genetic disorders
5. High heterogeneity for cystic fibrosis in Spanish families: 75 Mutations account for 90% of chromosomes
6. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre
7. Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene
8. Disease knowledge and reproductive attitudes of parents having a child with cystic fibrosis
9. Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients
10. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
11. Nachweis des HFE-Polymorphismus bei deutschen Patienten mit hereditärer Hämochromatose
12. Complexity in a monogenic disease
13. Nutritional benefits of neonatal Screening for cystic fibrosis
14. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
15. 2-microglobulin interaction and cell surface expression
16. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
17. Detection of over 98% cystic fibrosis mutations in a Celtic population
18. HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis
19. Prevalence of the mutations C282Y and H63D in the HFE gene among German hemochromatosis patients and healthy controls
20. Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference
21. Utilization of prenatal diagnosis for cystic fibrosis over the past seven years
22. Identification of the cystic fibrosis gene: Genetic analysis
23. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor
24. Prevalence of haemochromatosis amongst asymptomatic Australians
25. A survey of 2851 patients with hemochromatosis: Symptoms and response to treatment
26. Screening for cystic fibrosis
27. Long-term survival in patients with hereditary hemochromatosis
28. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany
29. A population-based study of the clinical expression of the hemochromatosis gene
30. Analysis of the CFTR gene in Turkish cystic fibrosis patients: Identification of three novel mutations (3172delAC, P1013L and M10281)
31. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
32. Haemochromatosis, HFE and genetic complexity
33. Identification of the cystic fibrosis gene: Chromosome walking and jumping
34. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls
35. A commentary on the NIH consensus development statement "genetic testing for cystic fibrosis"
36. Cystic fibrosis mutation analysis: Report from 22 U K regional genetics laboratories
37. Idiopathic hemochromatosis: Demonstration of recessive transmission and early detection by family HLA typing
38. Detection of 100% of CFTR mutations in 63 CF families from Tyrol
39. Population variation of common cystic fibrosis mutations
40. Characterization of more than 85% of cystic fibrosis alleles in the Greek population including five novel mutations
41. Cystic fibrosis
42. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13